Market Research Logo

Cardiology Surgical & Interventional Cardiology Devices Market - Cardiac Surgery, Cardiac Rhythm Management, valvular heart disease, Vascular Closure, Cardiac Surgery, CABG, Market Research, cardiology medical devices, Market Size, Market Share, Global Tr

Cardiology Surgical & Interventional Cardiology Devices Market - Cardiac Surgery, Cardiac Rhythm Management, valvular heart disease, Vascular Closure, Cardiac Surgery, CABG, Market Research, cardiology medical devices, Market Size, Market Share, Global Trends & Competitive Analysis, Forecast 2014-2021

Cardiovascular Surgical & Interventional Cardiology devices market, which has wide range of diagnostics and therapeutic devices that are used in surgeries, is expected to show a double-digit growth from 2014 to 2021. Different cardiovascular surgeries require different types of surgical approach and devices.

This report briefly explains various cardiovascular surgeries like Heart Valve Repair or Replacement, Coronary Artery Bypass Grafting, Heart Transplant etc. Open Heart Surgery, Off-Pump Heart Surgery, and Minimally Invasion Heart Surgery are the different surgical approaches used for these surgeries. Geographically, US have the largest share with 46%, followed by the European market with 27% share in the surgical devices market.

This report includes a brief market overview, market analysis, and current and future prospects of the Global Cardiology Surgical and Interventional Cardiology device market. Marketers need such data on volume and value change, distribution trends and market prospects to effectively implement their planning strategies.

The report also highlights the geographical analysis of the market. The analysis is done on country level to provide better understanding of the market. The report gives information about market share analysis and value chain analysis provide information about the market participants.

Key companies profiled include

1. Boston Scientific Corporation
2. CR Bard
3. Medtronic
4. Abbot Laboratories
5. St Jude Medical
6. Cook Medical
7. Biosense Webster
8. Edwards Lifescience
9. Toshiba Medical Systems
10. Lombard Medical
11. Atricure Inc
12. Atrium Medical Corporation
13. Hansen Medical
14. GE Healthcare
15. Philips Healthcare
16. Smith Medical
17. Berlin Heart
18. Cambridge Heart, Inc
19. Johnson & Johnson

This report covers

  • The market growth from the period 2014-2021 in different countries and regions including coverage of regulations
  • The CAGR upto 2021 of market segments by application and type
  • Market Size, Share, Trends, Opportunities, Regional and Global Demand to understand the fastest growing markets and the factors for growth.
  • Insights and Analysis of the market
  • The report covers the market landscape and its growth prospects in the coming years.
  • Profiling of both established as well as upcoming companies in the market.
  • Tables, graphs and figures to for a better visceral understanding of the market
Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


This report provides detailed analysis of Global Cardiology Surgical & Interventional Cardiology Devices market. This report includes a brief market overview, market share analysis, and current market size, future forecast and key strategies of market leader which provide complete market scenario to the marketers to confidently update their strategic and tactical plans.

Marketers need data on volume and value changes, brand dynamics and distribution trends in order to effectively plan strategies.

Report includes detailed geographical analysis of Cardiology Surgical & Interventional Cardiology Devices market. Market analysis is done at country level to provide better understanding of the market. Market share analysis and value chain analysis of polyurethane market provides information about market participants.

Chap 1.Executive summary
Chap 2.Market overview
2.1.Market Estimation Methodology
2.2.Value Chain analysis
2.2.1.Suppliers
2.2.2.Manufacturers
2.2.3.Distributors & Retailers
2.2.4.End Users
2.3.Key Buying Criteria
2.3.1.Quality
2.3.2.Price
2.3.3.Availability
2.3.4.Success rate
2.4.Key Strategies
2.4.1.Innovation Is The Key Industry Strategy to Overcome Competition
2.5.Partnerships, acquisitions and mergers
2.6.Product Launch- a make or break marketing strategy
Chap 3.Market determinants
3.1.Drivers
3.1.1.Global increase in life style oriented diseases & fatalities
3.1.2.Medical Tourism
3.1.3.Medical Tourism Organizations
3.1.4.Global increase in healthcare spending
3.1.5.Increasing awareness of healthy lifestyle to drive the market
3.2.Restraints
3.2.1.High Cost of Surgeries
3.2.2.Stringent government policies affect Cardiology market growth
3.3.Opportunities
3.3.1.Research and development to explore healthcare robotics
3.3.2.Technological advancements in surgeries
3.3.3.US FDA approved medical devices
3.4.Challenges
3.4.1.High cost and Adoption issues of medical devices for hospitals and clinics
3.4.2.Reliability Issues
Chap 4.Market Segmentation
4.1.Cardiac rhythm management
4.1.1.Cardiac rhythm management devices
4.1.2.ICD: Cardioverter/defibrillators (ICD's)
4.1.3.Atrial Fibrillation
4.1.3.1.Treatment Options for Atrial Fibrillation
4.1.3.2.Cox-Maze Open Heart Procedure
4.1.3.3.Catheter-based Cardiac Ablation Procedure
4.2.Surgery
4.2.1.Coronary arteries bypass grafting (CABG)
4.2.2.Angioplasty
4.2.3.Transmyocardial Laser Revascularization (TMR)
4.2.4.Heart valve Repair/Replacement
4.2.5.Arrhythmia Treatment
4.2.6.Aneurysm Repair
4.2.7.Heart Transplant
4.2.7.1.Surgery to Place Ventricular Assist Devices or Total Artificial Hearts
4.2.8.Open Heart Surgery
4.2.9.Types of open heart surgery
4.2.10.Off Pump Heart surgery
4.2.11.Minimally invasive surgeries
4.3.Imaging Devices
4.3.1.Still Imaging
4.3.2.Real time imaging
4.3.3.Magnetic Resonance Angiogram (MRA)
4.3.4.Fluoroscopy
4.3.5.Echocardiography
4.4.Cardiac Catheterization
Chap 5.Geographical Analysis
5.1.North America
5.1.1.United States (U.S.)
5.1.1.1.US FDA is vigilant over interventional cardiology device market
5.1.2.Canada
5.1.2.1.CVD and other heart diseases are the leading cause of mortality in Canada
5.1.2.2.Regulations in Canada
5.2.Europe
5.2.1.United Kingdom (UK)
5.2.2.France
5.2.3.Germany
5.2.4.Italy
5.2.5.Spain
5.3.Asia Pacific
5.3.1.India
5.3.2.China
5.3.2.1.Diseases prevalent in China
5.3.3.Japan
5.3.4.Korea
5.3.5.Taiwan
5.4.Rest of the World
5.4.1.Brazil
5.4.2.Mexico
5.4.3.South Africa
Chap 6.Corporate profile
6.1.Boston Scientific Corporation
6.1.1.Overview
6.1.2.Boston Scientific Corporation products portfolio in Cardiac
6.1.3.SCOT Analysis
6.2.C.R. Bard
6.2.1.Overview
6.2.2.Bard product portfolio in Cardiac
6.2.3.SCOT Analysis
6.3.Medtronic
6.3.1.Overview
6.3.2.Medtronic product portfolio in Cardiac
6.3.3.Strategic Moves
6.3.4.SCOT Analysis
6.4.Abbot Laboratories
6.4.1.Overview
6.4.2.Abbott laboratories portfolio in cardiac
6.4.3.SCOT Analysis
6.5.St. Jude Medical
6.5.1.Overview
6.5.2.St. Jude medical products portfolio in cardiac
6.5.3.SCOT Analysis
6.6.Cook Medical
6.6.1.Overview
6.6.2.Cook Medical products portfolio in cardiac:
6.6.3.Strategic moves
6.6.4.SCOT Analysis
6.7.Biosense Webster
6.7.1.Overview
6.7.2.Biosense Webster products portfolio in cardiac
6.7.3.SCOT Analysis
6.8.Edwards Lifescience
6.8.1.Overview
6.8.2.Edwards Lifesciences products portfolio in cardiac
6.8.3.Strategic moves
6.8.4.SCOT Analysis
6.9.Toshiba Medical Systems
6.9.1.Overview
6.9.2.Toshiba Medical System Products Portfolio in Cardiac
6.9.3.SCOT Analysis
6.10.Lombard Medical
6.10.1.Overview
6.10.2.Lombard Medical products portfolio in cardiac
6.10.3.SCOT Analysis
6.11.Atricure Inc
6.11.1.Overview
6.11.2.Atricure products portfolio in cardiac
6.11.3.SCOT Analysis
6.12.Atrium Medical Corporation
6.12.1.Overview
6.12.2.Atrium Medical products portfolio in cardiac
6.12.3.SCOT Analysis
6.13.Hansen Medical
6.13.1.Overview
6.13.2.Hansen medical Product Portfolio
6.13.3.SCOT Analysis
6.14.GE Healthcare
6.14.1.Overview
6.14.2.GE Healthcare Product Portfolio
6.14.3.Strategic Moves
6.14.4.SCOT Analysis
6.15.Philips Healthcare
6.15.1.Overview
6.15.2.Phillips Healthcare Products Portfolio in Cardiac
6.15.3.Strategic Moves (2013-14)
6.15.4.SCOT Analysis
6.16.Smith Medical
6.16.1.Overview:134
6.16.2.Smiths Medical Products Portfolio in Cardiac
6.16.3.SCOT Analysis
6.17.Berlin Heart
6.17.1.Overview
6.17.2.Berlin heart product portfolio in Cardiac
6.17.3.Strategic Moves (2013-2014)
6.17.4.SCOT Analysis
6.18.Cambridge Heart, Inc.
6.18.1.Overview
6.18.2.Cambridge heart product portfolio in Cardiac
6.18.3.SCOT Analysis
6.19.Johnson & Johnson
6.19.1.Overview
6.19.2.SCOT Analysis
Table List
TABLE 1 Global cardiology surgical devices market by segments, 2013-2021, (in $million)
TABLE 2 Fact sheet of CVD fatalities
TABLE 3 Price difference in India and US for cardiac related surgeries
TABLE 4 Health expenditure per capita increased from 2010 to 2014 (in US $)
TABLE 5 Type of surgery and price in 2012 in the US
TABLE 6 USFDA Approvals in 2014
TABLE 7 Global CRDM market b y regions, 2013-2021 (in $million)
TABLE 8 Global CRDM market by devices, 2013-2021 (in $million)
TABLE 9 Global defibrillation systems market, by regions, 2013-2021 (in million)
TABLE 10 Global Atrial fibrillation systems market, by regions, 2013-2021 (in million)
TABLE 11 Global Coronary surgery market, by regions, 2013-2021, (in $million)
TABLE 12 Global Cardiac Surgery market by regions, 2013-2021, (in $million)
TABLE 13 Global Transmyocardial Laser Revascularization (TMR) market, by regions, 2013-2021
TABLE 14 Global Heart Valve replacement market by regions, 2013-2021, (in $million)
TABLE 15 Global heart transplant surgery market, by regions, 2013-2021 (in $million)
TABLE 16 Global Cardiac Imaging market, by regions, 2013-2021, (in $ million)
TABLE 17 Global Cardiac Stents market, by regions, 2013-2021 (in $million)
TABLE 18 Global Cardiac catheters market, by regions, 2013-2021, (in $million)
TABLE 19 Global cardiology surgery market, by regions, 2013-2021 (in $million)
TABLE 20 North America cardiology surgical market, by regions, 2013-2021 (in $million)
TABLE 21 Europe cardiology surgical market by regions, 2013-2021, (in $million)
TABLE 22 Fatality in Europe in 2014
TABLE 23 CVD statistics of the UK in 2014
TABLE 24 Number of cardiologists in Spain
TABLE 25 Asia Pacific cardiology surgical market by regions, 2013-2021, (in $million)
TABLE 26 Cost of surgeries in Taiwan in 2013
TABLE 27 ROW cardiology surgical market by regions, 2013-2021, (in $million)
Figures List
FIGURE 1 Market Share (%) of key players in the CRDM segment, 2013
FIGURE 2 Market Share (%) of key players in the Stents segment, 2013
FIGURE 3 Market Share (%) of key players in the Catheters segment, 2013
FIGURE 4 Global mortality rates for coronary heart disease, 2013
FIGURE 5 Fatalities increasing due to life style oriented diseases (in thousands),2013
FIGURE 6 United States Cardiology Surgical market, 2013-2021 (in $million)
FIGURE 7 CVD prevalence in Canada,2013
FIGURE 8 Canada cardiology surgical market, 2013-2021 (in $million)
FIGURE 9 Men Vs Women fatality rates in Europe 2014
FIGURE 10 United Kingdom cardiology surgical market, 2013-2021, (in $million)
FIGURE 11 France cardiology surgical market, 2013-2021 (in $million)
FIGURE 12 Germany cardiology surgical market, 2013-2021, (in $million)
FIGURE 13 Italy Cardiology surgery market, 2013-2021, (in $million)
FIGURE 14 India cardiology surgical market, 2013-2021, (in $million)
FIGURE 15 China cardiology surgical market, 2013-2021, (in $million)
FIGURE 16 Japan cardiology surgical market, 2013-2021, (in $million)
FIGURE 17 South Korea cardiology surgical market, 2013-2021, (in $million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report